SAN CLEMENTE, Calif., June 01, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, is uniquely qualified to address toxicity in the human body through his use of EDTA Chelation Therapy.
Dr. Steenblock uses EDTA (EthyleneDiamineTetraAcetic Acid) Chelation Therapy, a procedure that removes heavy metals from the blood, and consistently improves blood flow and relieves symptoms associated with atherosclerosis in over 80% of patients treated.
“It’s been observed that patients being treated for acute lead intoxification with EDTA with cardiovascular disease, showed improved stress tolerance and less chest pain with physical exertion, “ said Dr. Steenblock.
Dr. Steenblock believes that the benefits of EDTA chelation can improve circulation; reduce cholesterol levels, decrease high blood pressure; and lower insulin requirements in diabetics.
In addition, Dr. Steenblock uses EDTA Chelation Therapy with a combination of hyperbaric oxygen therapy, leading to significant neurologic improvements for stroke patients.
Dr. David Steenblock is a leading-edge physician in many fields of medicine, from stroke care, to acute brain trauma, to generative and cell-based medicine in the treatment of ALS, Cerebral Palsy and other chronic and degenerative diseases. For more information about Dr. Steenblock’s work in stem cell therapies, visit www.stemcellmd.org.
CONTACT: Irene Doti [email protected]


Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
CATL Stock Hits Record High After Q1 2025 Earnings Surge
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 



